![](/img/cover-not-exists.png)
The Clinical and Cost Effectiveness of Dasatinib Versus Nilotinib for The First and Second Line Treatment of People with Chronic Myeloid Leukaemia
Ward, T, Jones, B, Harrison, JP, Hurst, M, Tyas, D, McEwan, P, Gordon, JVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.201
Date:
October, 2017
File:
PDF, 60 KB
english, 2017